As per Intent Market Research, the Vitamin K2 Market was valued at USD 389.4 million in 2023 and will surpass USD 831.6 million by 2030; growing at a CAGR of 11.4% during 2024 - 2030.
The Vitamin K2 market is rapidly gaining traction, driven by its increasing importance in supporting bone and cardiovascular health. As an essential nutrient, Vitamin K2 plays a pivotal role in calcium regulation, ensuring that it is deposited in the bones and teeth rather than the arteries, which prevents arterial calcification. The growing awareness about the benefits of Vitamin K2 in supporting bone density, heart health, and overall wellness has resulted in an expanding market for supplements and fortified foods. As demand increases, innovations in production, along with a diverse range of product formats, are facilitating the accessibility and consumption of Vitamin K2, contributing to its market growth.
Among the different types of Vitamin K2, MK-7 (Menaquinone-7) is the fastest-growing subsegment, largely due to its superior bioavailability and longer half-life compared to other forms like MK-4. MK-7 is derived from natto, a traditional Japanese fermented food, and is widely used in dietary supplements due to its efficacy in maintaining bone health and preventing cardiovascular diseases. Studies have shown that MK-7 is more readily absorbed by the body, making it a preferred choice for both consumers and manufacturers in the health and wellness industry.
As a result, MK-7 has seen a surge in demand, particularly in the Western markets, where consumers are becoming more health-conscious and seeking products that can effectively support bone health, cardiovascular well-being, and overall vitality. The growing adoption of MK-7 supplements in mainstream health and wellness routines is expected to drive the expansion of this subsegment in the coming years.
The Animal-Based source segment remains the largest in the Vitamin K2 market, owing to the higher nutritional value and bioavailability of Vitamin K2 derived from animal-based products. These sources typically include egg yolks, dairy products, and certain meats, which naturally contain MK-4, a potent form of Vitamin K2. Since MK-4 is the most bioavailable form of Vitamin K2, it has long been the preferred choice for supplementation. Moreover, animal-based Vitamin K2 sources are often perceived as more effective by consumers seeking high-quality supplements that can yield noticeable health benefits.
This segment’s dominance is bolstered by the consistent demand for Vitamin K2 in the pharmaceutical industry and the growth of functional foods and beverages. Additionally, consumer preference for animal-based sources remains strong, especially in markets with a high consumption of dairy and animal products, such as Europe and North America.
Among the various forms of Vitamin K2 supplements, Softgels & Tablets are the largest subsegment, primarily driven by their consumer convenience, precise dosage, and ease of consumption. Softgels and tablets offer a practical solution for those looking to integrate Vitamin K2 into their daily health regimen without any hassle. These forms are particularly popular among adults and geriatrics, who are the primary consumers of dietary supplements for bone health and cardiovascular support.
Additionally, softgels and tablets are highly preferred by manufacturers as they can effectively protect the integrity of the active ingredients, ensuring longer shelf life and consistent potency. The ongoing innovation in supplement formulations, which includes improved delivery systems for enhanced absorption, further fuels the popularity of this subsegment in the global market.
Dietary Supplements remain the largest application for Vitamin K2, driven by the growing consumer awareness surrounding bone health and the increasing prevalence of conditions such as osteoporosis and cardiovascular diseases. Vitamin K2 is widely recognized for its role in bone mineralization and its ability to regulate calcium in the body, preventing calcium buildup in the arteries. As the global population ages, there is a heightened demand for supplements that support bone density and overall skeletal health.
In addition to the rising geriatric population, dietary supplements are also gaining popularity among younger demographics, particularly in health-conscious markets. The growing awareness of Vitamin K2's health benefits is expected to continue propelling this segment, with new products entering the market targeting both preventive care and active health management.
In the Adults end-user segment, Vitamin K2 is primarily consumed to prevent age-related bone loss and support cardiovascular health. The adult demographic, particularly those in their 30s to 50s, is increasingly focused on preventive health strategies, leading to a growing demand for supplements that can maintain bone density, prevent osteoporosis, and improve heart health. As adults are becoming more proactive in managing their long-term health, Vitamin K2 has gained significant traction due to its proven efficacy in promoting bone health and cardiovascular function.
The focus on adult consumers is evident in the rapid expansion of the dietary supplements market, with adult-targeted Vitamin K2 products being marketed for their preventive and therapeutic benefits. This demographic is expected to continue driving the growth of Vitamin K2 supplements as part of an overall trend toward healthier, more active lifestyles.
The Online Sales distribution channel is experiencing the fastest growth in the Vitamin K2 market, primarily due to the expanding reach of e-commerce and online retail platforms. Consumers increasingly prefer the convenience of purchasing supplements from the comfort of their homes, especially with the added benefit of accessing a wide range of products and competitive prices. Online platforms also provide an easy way for consumers to compare different Vitamin K2 brands, read reviews, and choose products that best suit their needs.
This growth in online sales is also fueled by the increasing trust in online retailers, coupled with the rise of digital marketing and influencer-driven trends. The accessibility of Vitamin K2 supplements through online platforms, including major e-commerce websites like Amazon, has greatly contributed to the fast-paced expansion of this segment.
The Asia-Pacific (APAC) region is the fastest-growing market for Vitamin K2, driven by an increase in health awareness, rising disposable incomes, and a growing aging population. Countries like Japan, China, and India are witnessing a surge in demand for Vitamin K2 supplements, particularly for bone health and cardiovascular support. Japan, in particular, has a long-standing tradition of consuming natto (fermented soybeans), which is a natural source of MK-7, contributing to a high level of awareness regarding the benefits of Vitamin K2.
As consumers in APAC continue to embrace Western health trends, including dietary supplements and functional foods, the region is expected to remain a key growth driver for the Vitamin K2 market. The increasing penetration of e-commerce in countries like China and India further supports the expansion of Vitamin K2 products across the region.
Key players in the global Vitamin K2 market include Kappa Bioscience, Nutraceutical Corporation, BASF SE, DSM Nutritional Products, and MenaQ7 (Novo Nordisk). These companies have been pivotal in driving innovation in Vitamin K2 production, particularly MK-7, and have strategically expanded their product portfolios to cater to the growing demand for both dietary supplements and functional foods. The competitive landscape is characterized by product diversification, with many companies focusing on improving bioavailability, sustainability, and sourcing from plant-based and synthetic alternatives.
The market is highly competitive, with both large multinational corporations and specialized players competing for market share. Companies are increasingly focusing on expanding distribution channels, particularly online sales, and forging partnerships with health and wellness brands to capture the growing consumer interest in preventive healthcare and natural supplements. As the market evolves, leading companies are expected to continue investing in research and development to enhance the efficacy and accessibility of Vitamin K2 products
Report Features |
Description |
Market Size (2023) |
USD 389.4 Million |
Forecasted Value (2030) |
USD 831.6 Million |
CAGR (2024 – 2030) |
11.4% |
Base Year for Estimation |
2023 |
Historic Year |
2022 |
Forecast Period |
2024 – 2030 |
Report Coverage |
Market Forecast, Market Dynamics, Competitive Landscape, Recent Developments |
Segments Covered |
Vitamin K2 Market By Type (MK-4, MK-7, Others), By Source (Animal-Based, Plant-Based, Synthetic), By Form (Powder, Liquid, Softgels & Tablets, Capsules), By Application (Dietary Supplements, Functional Foods & Beverages, Pharmaceuticals, Animal Feed, Cosmetics), By End-User (Infants, Children, Adults, Geriatrics), and By Distribution Channel (Online Sales, Offline Sales) |
Regional Analysis |
North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, South Korea, Australia, India, and Rest of Asia-Pacific), Latin America (Brazil, Argentina, and Rest of Latin America), Middle East & Africa (Saudi Arabia, UAE, Rest of Middle East & Africa) |
Major Companies |
Kappa Bioscience, Nutraceutical Corporation, DSM Nutritional Products, BASF SE, Chong Kun Dang Pharmaceutical Corp., NattoPharma, Frutarom Health, MenaQ7 (Novo Nordisk), Herbalife Nutrition, Amway, Bionova, Swisse Wellness, Tishcon Corporation, Jarrow Formulas, BioGenetics |
Customization Scope |
Customization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements |
1. Introduction |
1.1. Market Definition |
1.2. Scope of the Study |
1.3. Research Assumptions |
1.4. Study Limitations |
2. Research Methodology |
2.1. Research Approach |
2.1.1. Top-Down Method |
2.1.2. Bottom-Up Method |
2.1.3. Factor Impact Analysis |
2.2. Insights & Data Collection Process |
2.2.1. Secondary Research |
2.2.2. Primary Research |
2.3. Data Mining Process |
2.3.1. Data Analysis |
2.3.2. Data Validation and Revalidation |
2.3.3. Data Triangulation |
3. Executive Summary |
3.1. Major Markets & Segments |
3.2. Highest Growing Regions and Respective Countries |
3.3. Impact of Growth Drivers & Inhibitors |
3.4. Regulatory Overview by Country |
4. Vitamin K2 Market, by Type (Market Size & Forecast: USD Million, 2022 – 2030) |
4.1. MK-4 (Menaquinone-4) |
4.2. MK-7 (Menaquinone-7) |
4.3. Others (MK-6, MK-8, MK-9) |
5. Vitamin K2 Market, by Source (Market Size & Forecast: USD Million, 2022 – 2030) |
5.1. Animal-Based |
5.2. Plant-Based |
5.3. Synthetic |
6. Vitamin K2 Market, by Form (Market Size & Forecast: USD Million, 2022 – 2030) |
6.1. Powder |
6.2. Liquid |
6.3. Softgels & Tablets |
6.4. Capsules |
7. Vitamin K2 Market, by Application (Market Size & Forecast: USD Million, 2022 – 2030) |
7.1. Dietary Supplements |
7.2. Functional Foods & Beverages |
7.3. Pharmaceuticals |
7.4. Animal Feed |
7.5. Cosmetics |
8. Vitamin K2 Market, by End-User (Market Size & Forecast: USD Million, 2022 – 2030) |
8.1. Infants |
8.2. Children |
8.3. Adults |
8.4. Geriatrics |
9. Vitamin K2 Market, by Distribution Channel (Market Size & Forecast: USD Million, 2022 – 2030) |
9.1. Online Sales |
9.2. Offline Sales (Pharmacies, Supermarkets, Health Stores) |
10. Regional Analysis (Market Size & Forecast: USD Million, 2022 – 2030) |
10.1. Regional Overview |
10.2. North America |
10.2.1. Regional Trends & Growth Drivers |
10.2.2. Barriers & Challenges |
10.2.3. Opportunities |
10.2.4. Factor Impact Analysis |
10.2.5. Technology Trends |
10.2.6. North America Vitamin K2 Market, by Type |
10.2.7. North America Vitamin K2 Market, by Source |
10.2.8. North America Vitamin K2 Market, by Form |
10.2.9. North America Vitamin K2 Market, by Application |
10.2.10. North America Vitamin K2 Market, by |
10.2.11. North America Vitamin K2 Market, by Distribution Channel |
10.2.12. By Country |
10.2.12.1. US |
10.2.12.1.1. US Vitamin K2 Market, by Type |
10.2.12.1.2. US Vitamin K2 Market, by Source |
10.2.12.1.3. US Vitamin K2 Market, by Form |
10.2.12.1.4. US Vitamin K2 Market, by Application |
10.2.12.1.5. US Vitamin K2 Market, by |
10.2.12.1.6. US Vitamin K2 Market, by Distribution Channel |
10.2.12.2. Canada |
10.2.12.3. Mexico |
*Similar segmentation will be provided for each region and country |
10.3. Europe |
10.4. Asia-Pacific |
10.5. Latin America |
10.6. Middle East & Africa |
11. Competitive Landscape |
11.1. Overview of the Key Players |
11.2. Competitive Ecosystem |
11.2.1. Level of Fragmentation |
11.2.2. Market Consolidation |
11.2.3. Product Innovation |
11.3. Company Share Analysis |
11.4. Company Benchmarking Matrix |
11.4.1. Strategic Overview |
11.4.2. Product Innovations |
11.5. Start-up Ecosystem |
11.6. Strategic Competitive Insights/ Customer Imperatives |
11.7. ESG Matrix/ Sustainability Matrix |
11.8. Manufacturing Network |
11.8.1. Locations |
11.8.2. Supply Chain and Logistics |
11.8.3. Product Flexibility/Customization |
11.8.4. Digital Transformation and Connectivity |
11.8.5. Environmental and Regulatory Compliance |
11.9. Technology Readiness Level Matrix |
11.10. Technology Maturity Curve |
11.11. Buying Criteria |
12. Company Profiles |
12.1. Kappa Bioscience |
12.1.1. Company Overview |
12.1.2. Company Financials |
12.1.3. Product/Service Portfolio |
12.1.4. Recent Developments |
12.1.5. IMR Analysis |
*Similar information will be provided for other companies |
12.2. Nutraceutical Corporation |
12.3. DSM Nutritional Products |
12.4. BASF SE |
12.5. Chong Kun Dang Pharmaceutical Corp. |
12.6. NattoPharma |
12.7. Frutarom Health |
12.8. MenaQ7 (Novo Nordisk) |
12.9. Herbalife Nutrition |
12.10. Amway |
12.11. Bionova |
12.12. Swisse Wellness |
12.13. Tishcon Corporation |
12.14. Jarrow Formulas |
12.15. BioGenetics |
13. Appendix |
A comprehensive market research approach was employed to gather and analyze data on the Vitamin K2 Market. In the process, the analysis was also done to analyze the parent market and relevant adjacencies to measure the impact of them on the Vitamin K2 Market. The research methodology encompassed both secondary and primary research techniques, ensuring the accuracy and credibility of the findings.
Secondary research involved a thorough review of pertinent industry reports, journals, articles, and publications. Additionally, annual reports, press releases, and investor presentations of industry players were scrutinized to gain insights into their market positioning and strategies.
Primary research involved conducting in-depth interviews with industry experts, stakeholders, and market participants across the E-Waste Management ecosystem. The primary research objectives included:
A combination of top-down and bottom-up approaches was utilized to analyze the overall size of the Vitamin K2 Market. These methods were also employed to assess the size of various subsegments within the market. The market size assessment methodology encompassed the following steps:
To ensure the accuracy and reliability of the market size, data triangulation was implemented. This involved cross-referencing data from various sources, including demand and supply side factors, market trends, and expert opinions. Additionally, top-down and bottom-up approaches were employed to validate the market size assessment.